NVIDIA Brings AI Assistants to Life With GeForce RTX AI PCs
June 02, 2024 08:41 ET
|
NVIDIA
TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced new NVIDIA RTX™ technology to power AI assistants and digital humans running on new GeForce RTX™ AI laptops. ...
Computer Industry Joins NVIDIA to Build AI Factories and Data Centers for the Next Industrial Revolution
June 02, 2024 08:35 ET
|
NVIDIA
Top Computer Manufacturers Unveil Array of Blackwell-Powered Systems Featuring Grace CPUs, NVIDIA Networking and InfrastructureBroad Portfolios Encompass Cloud, On-Premises, Embedded and Edge AI...
NVIDIA Supercharges Ethernet Networking for Generative AI
June 02, 2024 08:32 ET
|
NVIDIA
TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced widespread adoption of the NVIDIA Spectrum™-X Ethernet networking platform as well as an accelerated product...
GDRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
June 02, 2024 08:23 ET
|
Robbins Geller Rudman & Dowd LLP
SAN DIEGO, June 02, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the GoodRx class action lawsuit seeks to represent purchasers or acquirers of GoodRx Holdings, Inc....
NVIDIA NIM Revolutionizes Model Deployment, Now Available to Transform World’s Millions of Developers Into Generative AI Developers
June 02, 2024 08:13 ET
|
NVIDIA
150+ Partners Across Every Layer of AI Ecosystem Embedding NIM Inference Microservices to Speed Enterprise AI Application Deployments From Weeks to MinutesNVIDIA Developer Program Members Gain Free...
NVIDIA Releases Digital Human Microservices, Paving Way for Future of Generative AI Avatars
June 02, 2024 08:11 ET
|
NVIDIA
TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced the general availability of NVIDIA ACE generative AI microservices to accelerate the next wave of digital humans,...
Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
June 02, 2024 08:00 ET
|
Intellia Therapeutics, Inc.
Extended follow-up data reaching over two years in the earliest patients dosed reinforce the potential of NTLA-2002 to be a functional cure for people living with hereditary angioedema (HAE)Eight of...
CryptoHeap Launches Comprehensive Strategy for Crypto Staking Amidst Market Fluctuations
June 02, 2024 08:00 ET
|
CryptoHeap
Miami, FL, June 02, 2024 (GLOBE NEWSWIRE) -- In response to the ongoing volatility in the cryptocurrency markets, CryptoHeap, a leading provider of cryptocurrency staking services, has introduced...
William Miller Spearheads Launch of Pioneering OkayCoin Staking Protocol
June 02, 2024 08:00 ET
|
OkayCoin
Los Angeles, CA, USA , June 02, 2024 (GLOBE NEWSWIRE) -- Today, OkayCoin, a frontrunner in cryptocurrency staking solutions, marked a significant milestone with the announcement of the upcoming...
BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) Treatment
June 02, 2024 04:00 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., June 02, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence showing that patients with hereditary angioedema...
- June 02, 2024 08:35 ET Computer Industry Joins NVIDIA to Build AI Factories and Data Centers for the Next Industrial Revolution
- June 02, 2024 08:32 ET NVIDIA Supercharges Ethernet Networking for Generative AI